Recent Finacing
Recent Raise
Aldea Pharmaceuticals develops small‑molecule activators/modulators of the aldehyde dehydrogenase enzyme family (Aldas), advancing AD‑6626 oral and IV formulations for acute alcohol toxicity and Fanconi anemia clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors